1,5,6-TrihydroxyxanthoneCAS# 5042-03-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 5042-03-5 | SDF | Download SDF |
PubChem ID | 5281652 | Appearance | Powder |
Formula | C13H8O5 | M.Wt | 244.19 |
Type of Compound | Xanthones | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1,5,6-trihydroxyxanthen-9-one | ||
SMILES | C1=CC2=C(C(=C1)O)C(=O)C3=C(O2)C(=C(C=C3)O)O | ||
Standard InChIKey | QVQLOWQNIFSVLU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H8O5/c14-7-2-1-3-9-10(7)11(16)6-4-5-8(15)12(17)13(6)18-9/h1-5,14-15,17H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 1,5,6-Trihydroxyxanthone exhibits antibacterial activity against Gram-positive bacteria. |
Targets | EGFR | Antifection |
1,5,6-Trihydroxyxanthone Dilution Calculator
1,5,6-Trihydroxyxanthone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0952 mL | 20.4759 mL | 40.9517 mL | 81.9034 mL | 102.3793 mL |
5 mM | 0.819 mL | 4.0952 mL | 8.1903 mL | 16.3807 mL | 20.4759 mL |
10 mM | 0.4095 mL | 2.0476 mL | 4.0952 mL | 8.1903 mL | 10.2379 mL |
50 mM | 0.0819 mL | 0.4095 mL | 0.819 mL | 1.6381 mL | 2.0476 mL |
100 mM | 0.041 mL | 0.2048 mL | 0.4095 mL | 0.819 mL | 1.0238 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isorhamnetin-3-O-beta-D-Glucoside
Catalog No.:BCN1247
CAS No.:5041-82-7
- Isoliquiritin
Catalog No.:BCN5945
CAS No.:5041-81-6
- Juglanin
Catalog No.:BCN6505
CAS No.:5041-67-8
- 3-Nitropropionic acid
Catalog No.:BCC6303
CAS No.:504-88-1
- DL-Homocysteic acid
Catalog No.:BCN2233
CAS No.:504-33-6
- 4-Aminopyridine
Catalog No.:BCC5267
CAS No.:504-24-5
- Orcinol
Catalog No.:BCN5612
CAS No.:504-15-4
- (-)-di-de-Omethylgrandisin
Catalog No.:BCN7872
CAS No.:50393-98-1
- Cyclo(Phe-Gly)
Catalog No.:BCN2431
CAS No.:5037-75-2
- Apixaban
Catalog No.:BCC2295
CAS No.:503612-47-3
- Pentamidine dihydrochloride
Catalog No.:BCC5194
CAS No.:50357-45-4
- glucagon receptor antagonists 1
Catalog No.:BCC1593
CAS No.:503559-84-0
- Methyl 2alpha-hydroxyhardwickiate
Catalog No.:BCN7595
CAS No.:50428-93-8
- GW441756
Catalog No.:BCC5093
CAS No.:504433-23-2
- Araneosol
Catalog No.:BCN5613
CAS No.:50461-86-4
- Homopiperazine
Catalog No.:BCC8995
CAS No.:505-66-8
- 3-(Carboxymethylamino)propanoic acid
Catalog No.:BCN1791
CAS No.:505-72-6
- Fenspiride HCl
Catalog No.:BCC4659
CAS No.:5053-08-7
- Columbianadin
Catalog No.:BCN1275
CAS No.:5058-13-9
- Isojacareubin
Catalog No.:BCN6883
CAS No.:50597-93-8
- Arachidonic acid
Catalog No.:BCN2215
CAS No.:506-32-1
- Nervonic acid
Catalog No.:BCN8374
CAS No.:506-37-6
- Octacosanoic Acid
Catalog No.:BCN5395
CAS No.:506-48-9
- Niranthin
Catalog No.:BCN5614
CAS No.:50656-77-4
Antibacterial and EGFR-tyrosine kinase inhibitory activities of polyhydroxylated xanthones from Garcinia succifolia.[Pubmed:25460314]
Molecules. 2014 Nov 28;19(12):19923-34.
Chemical investigation of the methanol extract of the wood of Garcinia succifolia Kurz (Clusiaceae) led to the isolation of 1,5-dihydroxyxanthone (1), 1,7-dihydroxyxanthone (2), 1,3,7-trihydroxyxanthone (3), 1,5,6-Trihydroxyxanthone (4), 1,6,7-trihydroxyxanthone (5), and 1,3,6,7-tetrahydroxyxanthone (6). All of the isolated xanthones were evaluated for their antibacterial activity against bacterial reference strains, two Gram-positive (Staphylococcus aureus ATTC 25923, Bacillus subtillis ATCC 6633) and two Gram-negative (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853), and environmental drug-resistant isolates (S. aureus B1, Enteroccoccus faecalis W1, and E. coli G1), as well as for their epidermal growth factor receptor (EGFR) of tyrosine kinase inhibitory activity. Only 1,5,6-trihydroxy-(4), 1,6,7-trihydroxy-(5), and 1,3,6,7-tetrahydroxyxanthones (6) exhibited antibacterial activity against Gram-positive bacteria, however none was active against vancomycin-resistant E. faecalis. Additionally, 1,7-dihydroxyxanthone (2) showed synergism with oxacillin, but not with ampicillin. On the other hand, only 1,5-dihydroxyxanthone (1) and 1,7-dihydroxyxanthone (2) were found to exhibit the EGFR-tyrosine kinase inhibitory activity, with IC50 values of 90.34 and 223 nM, respectively.